Fentanyl can contribute to psychotic symptoms through several distinct pathways, though a straightforward “fentanyl causes psychosis” framing oversimplifies the picture. The drug is linked to hallucinations, paranoia, and disorganized thinking in some users, but these effects arise through different mechanisms depending on whether someone is actively intoxicated, going through withdrawal, recovering from an overdose, or unknowingly consuming fentanyl laced with other compounds. The evidence is clearer on some of these pathways than others, and separating fentanyl’s direct role from everything else happening in a person’s brain and body turns out to be surprisingly difficult.
Opioid-Induced Hallucinations Are a Recognized Side Effect
All opioids, fentanyl included, can cause hallucinations. A literature review published in Anesthesia & Analgesia characterized opioid-induced hallucination as “an uncommon yet significant adverse effect of opioid treatment.”1PubMed Central. Opioid-induced Hallucinations: A Review of the Literature, Pathophysiology, Diagnosis, and Treatment Most documented cases come from clinical settings like cancer pain management and end-of-life care, where patients receive sustained opioid doses under medical supervision. In those contexts, hallucinations are typically visual, sometimes accompanied by confusion, and usually resolve when the opioid is reduced or switched to a different drug.
Fentanyl stands out among opioids for its potency. It binds tightly to mu-opioid receptors and acts fast, which means the neurochemical disruption it causes is intense and rapid. Whether that potency translates into a higher rate of psychotic symptoms compared to other opioids is genuinely unclear. The clinical literature on opioid-induced hallucinations grew mostly out of morphine and hydromorphone use in palliative care, and large-scale comparisons between specific opioids and their rates of psychiatric side effects are thin. What is clear is that fentanyl shares the same basic mechanism, so the potential exists regardless of the route of exposure, whether that is a prescription patch, a diverted pill, or street powder.
The Dopamine Connection
One reason fentanyl could push someone toward psychotic symptoms involves dopamine. Psychosis in general is linked to excessive dopamine signaling in certain brain circuits, which is why most antipsychotic medications work by blocking dopamine receptors. Fentanyl directly increases dopamine release in a brain region called the nucleus accumbens, a key node in the brain’s reward system. Animal research has shown that fentanyl does this by activating mu-opioid receptors and a specific subtype of delta-opioid receptors in that area, and blocking either of those receptor types prevents the dopamine surge.2Neuroscience. Fentanyl increases dopamine release in rat nucleus accumbens: involvement of mesolimbic mu- and delta-2-opioid receptors
This dopamine release is what produces fentanyl’s euphoria and reinforces addiction. But that same surge, especially at high doses or in individuals whose dopamine regulation is already disrupted, could tip the balance toward psychotic-like experiences. Mu-opioid agonists primarily produce euphoria in humans, while kappa-opioid agonists tend to produce dysphoria and perceptual disturbances.3PubMed. Site of opioid action in the human brain: mu and kappa agonists’ subjective and cerebral blood flow effects Fentanyl is predominantly a mu agonist, so full-blown psychosis from its direct pharmacological action is not the most expected outcome. But at extreme doses, or in people with underlying vulnerability, the line between intense euphoria, confusion, and hallucinations can blur.
Overdose, Oxygen Loss, and Brain Damage
A pathway that gets less public attention than it deserves is what happens to the brain during and after a fentanyl overdose. Fentanyl suppresses breathing. When breathing stops or slows dramatically, the brain is starved of oxygen, and even a few minutes of severe oxygen deprivation can cause lasting damage. The resulting condition, sometimes called hypoxic-ischemic brain injury, can produce a range of neuropsychiatric symptoms including disorientation, paranoia, emotional instability, and executive function problems that look a lot like psychosis.
A case report in the American Journal of Physical Medicine & Rehabilitation described a 33-year-old patient who developed altered mental status, generalized weakness, and paranoia after a fentanyl overdose complicated by hypoxia. The authors noted that hallmark features of this kind of brain injury include attention and executive function deficits, emotional lability, and disorientation, signs commonly seen in people with substance use disorders.4American Journal of Physical Medicine & Rehabilitation. 33-Year-Old Man With Altered Mental Status, Generalized Weakness, and Paranoia Following Fentanyl Overdose In that case, the patient’s chronic alcohol use and a cocaine-fentanyl overdose with hypoxia all contributed, making it impossible to blame fentanyl alone. That complexity is typical rather than exceptional.
The crucial point is that someone who survives a fentanyl overdose and later develops psychotic symptoms may not be experiencing a direct drug effect at all. Their brain may have been physically injured by oxygen deprivation. The treatment and prognosis for post-anoxic neuropsychiatric symptoms are different from those for substance-induced psychosis, so the distinction matters clinically even though it is hard to make from the outside.
What Adulterants Add to the Picture
Street-level fentanyl is almost never pure fentanyl. It is commonly mixed with other substances, and one of the most concerning adulterants in recent years is xylazine, a veterinary tranquilizer that has no approved use in humans. Xylazine has its own set of dangerous effects, including severe sedation, respiratory depression, and a tendency to cause necrotic skin ulcers at injection sites. It also appears to worsen psychiatric symptoms.
A case report in the Journal of Medical Cases described a 37-year-old man with a history of polysubstance intravenous use, including fentanyl and methamphetamine, who presented to the emergency department with acute psychosis and worsening ulcerations across multiple fingers. The patient reported that the ulcerations started and progressed after he began injecting fentanyl cut with “tranq,” a street name for xylazine.5PubMed Central. A Case of Xylazine-Induced Necrotic Skin Ulcerations in an IV-Drug User in Florida This patient had a significant psychiatric history and was using methamphetamine concurrently, so isolating which substance triggered the acute psychosis is impossible. But the case illustrates a reality of the current drug supply: when someone using street fentanyl develops psychotic symptoms, the fentanyl may not be the only chemical involved, and the user often has no way of knowing what else they ingested.
Beyond xylazine, illicit fentanyl has been found mixed with stimulants like methamphetamine, benzodiazepines, and novel synthetic compounds that users may not even be aware of. Any of these could contribute to psychotic symptoms independently. A person who believes they are using fentanyl alone and then develops paranoia or hallucinations may attribute those symptoms to fentanyl when the true culprit is something else entirely.
Withdrawal as a Trigger
Fentanyl withdrawal is fast and brutal. Because the drug leaves the body quickly, withdrawal symptoms can start within hours of the last dose and peak with an intensity that many users describe as worse than withdrawal from heroin or prescription opioids. The classic symptoms of opioid withdrawal are physical: muscle pain, nausea, diarrhea, sweating, and chills. But severe withdrawal can also involve agitation, extreme anxiety, insomnia, and in some cases, frank psychotic symptoms like hallucinations and paranoia.
The mechanism behind withdrawal-related psychiatric symptoms is essentially the flip side of the dopamine story. Chronic opioid use downregulates the brain’s own dopamine and endorphin systems. When the drug is suddenly removed, the brain is left in a state of neurochemical deficit. This abrupt imbalance can destabilize mood, perception, and cognition. Sleep deprivation during withdrawal, which can be extreme, likely contributes as well. Going several days without meaningful sleep is itself enough to cause psychotic symptoms in otherwise healthy people.
Withdrawal psychosis is not unique to fentanyl. It has been documented with alcohol, benzodiazepines, and other opioids. But the intensity and speed of fentanyl withdrawal may make it more likely. There are no large studies specifically quantifying how often fentanyl withdrawal produces psychosis, so the evidence here relies on clinical observation and case reports rather than epidemiological data.
How Common Are Psychiatric Disorders Among Fentanyl Users?
A study published in Scientific Reports examined emergency department patients with illicit fentanyl use and found that roughly 36% had co-occurring psychiatric disorders. Among those with psychiatric diagnoses, mood disorders were the most common, accounting for about half. Psychotic disorders came second, affecting about one in five of those with a psychiatric diagnosis.6Scientific Reports. Co-occurring illicit fentanyl use and psychiatric disorders in emergency department patients That is a striking number, but it requires careful interpretation.
The study also found that patients with co-occurring psychiatric disorders had significantly higher rates of marijuana use compared to those without psychiatric diagnoses, but rates of other substance use, including heroin, cocaine, and methamphetamine, did not differ between the two groups.6Scientific Reports. Co-occurring illicit fentanyl use and psychiatric disorders in emergency department patients This is an important detail because it suggests that the link between fentanyl use and psychiatric disorders is not simply explained by heavier polysubstance use across the board.
Still, these numbers do not prove that fentanyl caused the psychotic disorders. Many people with psychotic disorders turn to opioids as a form of self-medication, and the relationship runs both ways. Emergency department populations are also not representative of all fentanyl users. People who end up in the ED are, by definition, in crisis, so the rate of psychiatric comorbidity in this group is likely higher than among the broader population of people who use fentanyl.
Telling Substance-Induced Psychosis Apart from a Primary Disorder
When someone arrives at a hospital in the middle of a psychotic episode and has recently used fentanyl, clinicians face a genuinely difficult diagnostic question: is this a primary psychotic disorder like schizophrenia that happened to co-occur with drug use, or did the drug trigger the episode? Getting this right matters because the treatment plan and long-term outlook differ considerably.
A study in JAMA Psychiatry examined nearly 400 patients with early-phase psychotic episodes and found that about 44% were diagnosed with substance-induced psychosis while 56% had a primary psychotic disorder. The substance-induced group was more likely to have visual hallucinations, a family history of parental substance abuse, and a diagnosis of drug dependence. Meanwhile, the primary psychosis group had higher overall scores on measures of positive and negative symptoms.7JAMA Network. Differences Between Early-Phase Primary Psychotic Disorders With Concurrent Substance Use and Substance-Induced Psychoses Visual hallucinations as a distinguishing feature is worth noting because opioid-induced hallucinations are also predominantly visual, fitting this pattern.
In practice, the distinction is often made retrospectively. If psychotic symptoms clear up within days to weeks of stopping the substance, clinicians lean toward a substance-induced diagnosis. If symptoms persist long after the drug has left the body, a primary disorder becomes more likely. Fentanyl complicates this timeline because withdrawal itself can sustain psychiatric symptoms for weeks, and some users cycle between intoxication and withdrawal so rapidly that there is no meaningful drug-free window to observe.
What Chronic Fentanyl Exposure Does to the Brain
Beyond acute effects, there is growing evidence that sustained fentanyl use reshapes the brain at a molecular level. A study in mice found that fentanyl exposure altered the expression of genes in the prefrontal cortex related to dopamine, serotonin, and GABA signaling, three neurotransmitter systems deeply involved in regulating mood, perception, and thought. The affected genes included several dopamine receptor subtypes and genes involved in synaptic structure and plasticity.8PubMed Central. Synaptic Structure and Transcriptomic Profiling of Reward and Sensory Brain Areas in Male Mice of Fentanyl Addiction These transcriptomic changes correlated with structural and behavioral changes in the exposed animals.
This is animal research, and translating mouse gene expression data directly to human psychiatric risk is a leap. But the findings align with what clinicians observe: people with long histories of fentanyl use often show cognitive and emotional changes that go beyond what you would expect from intoxication or withdrawal alone. Their brains appear to have been remodeled. Whether this remodeling reaches a threshold that produces psychotic symptoms likely depends on individual vulnerability, dose, duration, and co-occurring factors like other drug use or pre-existing mental health conditions.
Separate research on perinatal fentanyl exposure in mice found that newborns exposed to fentanyl showed signs of withdrawal and sensory-related deficits that persisted at least into adolescence.9PubMed Central. Perinatal Fentanyl Exposure Leads to Long-Lasting Impairments in Somatosensory Circuit Function and Behavior While this research focused on sensory processing rather than psychosis specifically, it demonstrates that fentanyl can cause lasting changes to developing brain circuits. The implications for the growing number of infants born with fentanyl exposure are concerning, though far too early to quantify in terms of psychiatric risk.
Why Fentanyl Makes the Question So Hard to Answer
If you compare fentanyl to stimulants like methamphetamine or cocaine, the psychosis connection is much less clear-cut. Stimulant-induced psychosis is well characterized, occurs commonly at high doses, and has a relatively straightforward mechanism tied to dopamine flooding. Fentanyl, by contrast, produces psychotic symptoms through a messy tangle of pathways: direct pharmacological effects on opioid and dopamine receptors, oxygen deprivation during overdose, withdrawal-related neurochemical crashes, adulterants in the drug supply, and long-term brain remodeling. Any given case probably involves more than one of these.
The research base is also tilted in ways that make confident conclusions difficult. Much of the clinical literature on opioid-induced hallucinations comes from palliative care settings where patients received pharmaceutical-grade opioids in controlled doses.1PubMed Central. Opioid-induced Hallucinations: A Review of the Literature, Pathophysiology, Diagnosis, and Treatment That tells us something about the drug’s pharmacology, but it does not map neatly onto what happens to a person injecting street fentanyl of unknown potency and composition, going through repeated cycles of intoxication and withdrawal, and living in conditions of chronic stress and sleep deprivation that independently raise psychosis risk.
Forensic and medicolegal cases occasionally highlight the real-world consequences. A case discussed in Forensic Science, Medicine and Pathology described a fatal incident involving an atypical stab wound inflicted during drug-induced psychosis, illustrating how psychotic states in people using illicit drugs can lead to unpredictable violence and complex legal situations.10Forensic Science, Medicine and Pathology. Determining the manner of death in victims in drug-induced psychosis: a case of an atypical head stab wound Cases like these underscore that regardless of which specific mechanism is at work, the co-occurrence of fentanyl use and psychosis is a real clinical and public safety concern.
Who Is Most Vulnerable
Not everyone who uses fentanyl develops psychotic symptoms, even at high doses. Several factors seem to increase the risk. People with a personal or family history of psychotic disorders are more susceptible, consistent with the broader principle that substance-induced psychosis tends to unmask latent vulnerability rather than creating it from scratch. Heavy polysubstance use, particularly involving stimulants, raises risk as well. Chronic sleep deprivation, social isolation, and the accumulated trauma that often accompanies long-term addiction all compound the problem.
Age may also matter, though the human data on adolescent fentanyl use and psychosis is limited. Adolescent brains are still developing, and the animal research on perinatal and early-life fentanyl exposure suggests that younger brains are more susceptible to lasting changes from the drug. The prefrontal cortex, which is responsible for executive function, impulse control, and reality testing, does not fully mature until the mid-twenties. Disrupting its development with a potent opioid during this window could plausibly increase vulnerability to psychotic symptoms, though this remains an area where animal data outpaces human evidence.
People who use fentanyl intravenously face additional risks because IV use produces the most rapid onset and highest peak blood levels, maximizing both the dopamine surge and the risk of overdose-related hypoxia. Smoking fentanyl, which has become more common in some regions, similarly produces a fast onset. Routes of administration that produce a slower rise in blood levels, like transdermal patches used in medical settings, appear to carry lower psychiatric risk, though they are not risk-free.